Preston Long
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Preston Long has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Tanja Stamm
Institute for Outcomes Research, Medical University of Vienna, Vienna, Austria
10 shared publications - Ann-Kristin Porth
Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University Vienna, 1090 Wien, Austria
4 shared publications - Valentin Ritschl
Institute for Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Wien, Austria
4 shared publications - Lisa Rebecca Otto
Charité - Universitätsmedizin Berlin, Berlin, Germany
3 shared publications - Margaret Renn Andrews
Institute for Outcomes Research, Medical University of Vienna, Vienna, Austria
3 shared publications - Alexandra Kautzky-Willer
Division of Endocrinology and Metabolism, Department of Medicine III Medical University of Vienna Vienna Austria
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e94733
Integrating Patient-Reported Outcome Measures Through the Health Outcomes Observatory (H2O) Digital Infrastructure: Multicenter Mixed Methods Feasibility Study
Background: The integration of patient-reported outcomes (PROs) into routine clinical practice remains limited despite their well-documented benefits in facilitating clinical communication and research. Systematic digital PRO collection can enable real-time symptom monitoring, timely clinical interventions, and greater patient empowerment. The Health Outcomes Observatory (H2O) initiative was developed to enable systematic digital patient-reported outcome measures (PROMs) collection and integration with clinical data to support value-based, patient-centered care across health care systems. Objective: This study aimed to evaluate the feasibility, usability, acceptability, clinical utility, and implementation of the H2O digital infrastructure from patient and health care professional perspectives across multiple health care settings and medical conditions. Methods: A noninterventional, multicenter, convergent mixed methods feasibility study was conducted in Spain, Austria, the Netherlands, and Germany across multiple medical conditions. Locally implemented smartphone, tablet, and web-based solutions captured and displayed PROs. Surveys and interviews assessed usability, acceptability, perceived clinical utility, and implementation conditions among patients and health care professionals. Results: Of 241 participants assessed initially, 115 (47.7%) contributed follow-up data. Although 83% (44/53) of the respondents indicated willingness to recommend H2O, the mean System Usability Scale (SUS) score was 44.65/100 (SD 9.78), indicating poor usability. Among 50 participants with paired Patient Satisfaction Questionnaire Short Form assessments, satisfaction with technical quality declined (t49=2.20; P=.03). Interviews identified perceived value alongside login difficulties, technical instability, weak integration with clinical systems, and inconsistent use of PRO data during consultations. Conclusions: The H2O infrastructure could be deployed across heterogeneous settings, and participants perceived value in digital PRO collection; however, poor usability, substantial attrition, technical friction, and limited workflow integration qualify conclusions about feasibility and acceptability. More reliable technology, stronger interoperability, and evaluation in larger and more complete samples are needed before broader implementation.
- 11 November 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e94733
Open AccessIntegrating Patient-Reported Outcome Measures Through the Health Outcomes Observatory (H2O) Digital Infrastructure: Multicenter Mixed Methods Feasibility Study
Background: The integration of patient-reported outcomes (PROs) into routine clinical practice remains limited despite their well-documented benefits in facilitating clinical communication and research. Systematic digital PRO collection can enable real-time symptom monitoring, timely clinical interventions, and greater patient empowerment. The Health Outcomes Observatory (H2O) initiative was developed to enable systematic digital patient-reported outcome measures (PROMs) collection and integration with clinical data to support value-based, patient-centered care across health care systems. Objective: This study aimed to evaluate the feasibility, usability, acceptability, clinical utility, and implementation of the H2O digital infrastructure from patient and health care professional perspectives across multiple health care settings and medical conditions. Methods: A noninterventional, multicenter, convergent mixed methods feasibility study was conducted in Spain, Austria, the Netherlands, and Germany across multiple medical conditions. Locally implemented smartphone, tablet, and web-based solutions captured and displayed PROs. Surveys and interviews assessed usability, acceptability, perceived clinical utility, and implementation conditions among patients and health care professionals. Results: Of 241 participants assessed initially, 115 (47.7%) contributed follow-up data. Although 83% (44/53) of the respondents indicated willingness to recommend H2O, the mean System Usability Scale (SUS) score was 44.65/100 (SD 9.78), indicating poor usability. Among 50 participants with paired Patient Satisfaction Questionnaire Short Form assessments, satisfaction with technical quality declined (t49=2.20; P=.03). Interviews identified perceived value alongside login difficulties, technical instability, weak integration with clinical systems, and inconsistent use of PRO data during consultations. Conclusions: The H2O infrastructure could be deployed across heterogeneous settings, and participants perceived value in digital PRO collection; however, poor usability, substantial attrition, technical friction, and limited workflow integration qualify conclusions about feasibility and acceptability. More reliable technology, stronger interoperability, and evaluation in larger and more complete samples are needed before broader implementation.
- Open Access
- 8 October 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1) , 184
Embedding patient voice within European healthcare: achievements and future directions of the health outcomes observatory
- 8 October 2026
- Published by Springer Nature in Journal of Patient-Reported Outcomes
- Vol. 10 (1) , 184
Open AccessEmbedding patient voice within European healthcare: achievements and future directions of the health outcomes observatory
- Open Access
- 1 June 2026
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 20, 1-9
Integrating Positive Outcomes into Healthcare: Validation of the Pleasurable Affect Levels Scale
Background: As value-based healthcare (VBHC) continues to reshape global health systems, there is growing recognition that patient-reported outcomes should track not only disease but also positive factors like wellness. Despite the centrality of pleasure to motivation, resilience, and quality of life, no instruments directly assess this construct. To address this gap, the present study developed and preliminarily validated the Pleasurable Affect Levels Scale (PALS), a novel, generic patient-reported outcome measure (PROM) designed to quantify the experience of pleasure relevant for clinical decision making. Methods: A scoping literature review was conducted to identify validated scales measuring pleasure or related constructs and inform the novel scale development. Four iterative rounds of pilot testing were carried out. Item generation and refinement were guided by patient feedback, expert consensus, and psychometric testing. Analyses included exploratory factor analysis (EFA) to examine construct validity, item reduction based on cross-loadings and redundancy, and reliability assessment via Cronbach’s alpha. Results: The literature review identified three validated scales (DARS, SAAS, SHAPS), each focused on anhedonia rather than pleasure itself. Final refinement across pilots yielded a final 23-item scale. Factor analysis supported a four-factor structure—functional maintenance, sensory input, social interaction, and leisure—with strong sampling adequacy (KMO = 0.941), significant Bartlett’s test (p < 0.05), and excellent internal consistency (α = 0.942). Conclusion: Preliminary findings indicate strong psychometric performance. The assessment of pleasure could have important implications for clinical practice, research, and health policy by enabling clinicians to quantify and track patient health beyond symptom reduction, support treatment decisions, and potentially improve adherence. By incorporating pleasure into patient care and dialogue, it may promote a more comprehensive approach to healthcare, although these applications require validation through real-world clinical implementation and testing. Plain Language Summary: The study developed a new patient-reported outcome measure called the Pleasurable Affect Levels Scale (PALS) to assess and track the pleasure patients experience in everyday life—something current tools do not directly assess. Early testing shows that the scale is reliable and captures different types of pleasure, like social, sensory, and leisure enjoyment. This tool may help clinicians better understand patients’ wellness and track improvements that go beyond symptom reduction.
- 1 June 2026
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 20, 1-9
Open AccessIntegrating Positive Outcomes into Healthcare: Validation of the Pleasurable Affect Levels Scale
Background: As value-based healthcare (VBHC) continues to reshape global health systems, there is growing recognition that patient-reported outcomes should track not only disease but also positive factors like wellness. Despite the centrality of pleasure to motivation, resilience, and quality of life, no instruments directly assess this construct. To address this gap, the present study developed and preliminarily validated the Pleasurable Affect Levels Scale (PALS), a novel, generic patient-reported outcome measure (PROM) designed to quantify the experience of pleasure relevant for clinical decision making. Methods: A scoping literature review was conducted to identify validated scales measuring pleasure or related constructs and inform the novel scale development. Four iterative rounds of pilot testing were carried out. Item generation and refinement were guided by patient feedback, expert consensus, and psychometric testing. Analyses included exploratory factor analysis (EFA) to examine construct validity, item reduction based on cross-loadings and redundancy, and reliability assessment via Cronbach’s alpha. Results: The literature review identified three validated scales (DARS, SAAS, SHAPS), each focused on anhedonia rather than pleasure itself. Final refinement across pilots yielded a final 23-item scale. Factor analysis supported a four-factor structure—functional maintenance, sensory input, social interaction, and leisure—with strong sampling adequacy (KMO = 0.941), significant Bartlett’s test (p < 0.05), and excellent internal consistency (α = 0.942). Conclusion: Preliminary findings indicate strong psychometric performance. The assessment of pleasure could have important implications for clinical practice, research, and health policy by enabling clinicians to quantify and track patient health beyond symptom reduction, support treatment decisions, and potentially improve adherence. By incorporating pleasure into patient care and dialogue, it may promote a more comprehensive approach to healthcare, although these applications require validation through real-world clinical implementation and testing. Plain Language Summary: The study developed a new patient-reported outcome measure called the Pleasurable Affect Levels Scale (PALS) to assess and track the pleasure patients experience in everyday life—something current tools do not directly assess. Early testing shows that the scale is reliable and captures different types of pleasure, like social, sensory, and leisure enjoyment. This tool may help clinicians better understand patients’ wellness and track improvements that go beyond symptom reduction.
- Open Access
- 6 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Integrating Patient-Reported Outcome Measures Through the Health Outcomes Observatory (H2O) Digital Infrastructure: Multicenter Mixed Methods Feasibility Study (Preprint)
BACKGROUND The integration of patient-reported outcomes (PROs) into routine clinical practice remains limited despite their well-documented benefits in facilitating clinical communication and research. Systematic digital PRO collection can enable real-time symptom monitoring, timely clinical interventions, and greater patient empowerment. The Health Outcomes Observatory (H2O) initiative was developed to enable systematic digital patient-reported outcome measures (PROMs) collection and integration with clinical data to support value-based, patient-centered care across health care systems. OBJECTIVE This study aimed to evaluate the feasibility, usability, acceptability, clinical utility, and implementation of the H2O digital infrastructure from patient and health care professional perspectives across multiple health care settings and medical conditions. METHODS A noninterventional, multicenter, convergent mixed methods feasibility study was conducted in Spain, Austria, the Netherlands, and Germany across multiple medical conditions. Locally implemented smartphone, tablet, and web-based solutions captured and displayed PROs. Surveys and interviews assessed usability, acceptability, perceived clinical utility, and implementation conditions among patients and health care professionals. RESULTS Of 241 participants assessed initially, 115 (47.7%) contributed follow-up data. Although 83% (44/53) of the respondents indicated willingness to recommend H2O, the mean System Usability Scale (SUS) score was 44.65/100 (SD 9.78), indicating poor usability. Among 50 participants with paired Patient Satisfaction Questionnaire Short Form assessments, satisfaction with technical quality declined (t49=2.20; P=.03). Interviews identified perceived value alongside login difficulties, technical instability, weak integration with clinical systems, and inconsistent use of PRO data during consultations. CONCLUSIONS The H2O infrastructure could be deployed across heterogeneous settings, and participants perceived value in digital PRO collection; however, poor usability, substantial attrition, technical friction, and limited workflow integration qualify conclusions about feasibility and acceptability. More reliable technology, stronger interoperability, and evaluation in larger and more complete samples are needed before broader implementation. CLINICALTRIAL
- 6 March 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIntegrating Patient-Reported Outcome Measures Through the Health Outcomes Observatory (H2O) Digital Infrastructure: Multicenter Mixed Methods Feasibility Study (Preprint)
BACKGROUND The integration of patient-reported outcomes (PROs) into routine clinical practice remains limited despite their well-documented benefits in facilitating clinical communication and research. Systematic digital PRO collection can enable real-time symptom monitoring, timely clinical interventions, and greater patient empowerment. The Health Outcomes Observatory (H2O) initiative was developed to enable systematic digital patient-reported outcome measures (PROMs) collection and integration with clinical data to support value-based, patient-centered care across health care systems. OBJECTIVE This study aimed to evaluate the feasibility, usability, acceptability, clinical utility, and implementation of the H2O digital infrastructure from patient and health care professional perspectives across multiple health care settings and medical conditions. METHODS A noninterventional, multicenter, convergent mixed methods feasibility study was conducted in Spain, Austria, the Netherlands, and Germany across multiple medical conditions. Locally implemented smartphone, tablet, and web-based solutions captured and displayed PROs. Surveys and interviews assessed usability, acceptability, perceived clinical utility, and implementation conditions among patients and health care professionals. RESULTS Of 241 participants assessed initially, 115 (47.7%) contributed follow-up data. Although 83% (44/53) of the respondents indicated willingness to recommend H2O, the mean System Usability Scale (SUS) score was 44.65/100 (SD 9.78), indicating poor usability. Among 50 participants with paired Patient Satisfaction Questionnaire Short Form assessments, satisfaction with technical quality declined (t49=2.20; P=.03). Interviews identified perceived value alongside login difficulties, technical instability, weak integration with clinical systems, and inconsistent use of PRO data during consultations. CONCLUSIONS The H2O infrastructure could be deployed across heterogeneous settings, and participants perceived value in digital PRO collection; however, poor usability, substantial attrition, technical friction, and limited workflow integration qualify conclusions about feasibility and acceptability. More reliable technology, stronger interoperability, and evaluation in larger and more complete samples are needed before broader implementation. CLINICALTRIAL
- Open Access
- 12 December 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (24) , 3272
Tracking Chronic Diseases via Mobile Health Applications: Which User Experience Aspects Are Key?
Background: A key barrier to realizing the full potential and long-term collection of patient-reported outcomes (PROs) is the limited understanding of user experience (UX) factors that influence sustained patient engagement with digital PRO tools. Most existing research focuses on disease-specific or country-specific solutions, leaving a gap in identifying shared UX determinants that could inform scalable, cross-disease European digital health frameworks. This fragmentation hinders interoperability and increases development costs by requiring separate tools for each context. This case study aims to address this gap by identifying key UX features that optimize PRO collection across diverse chronic conditions in Europe within the Health Outcomes Observatory project, enhancing continuous (primary use) and large-scale (secondary use) data collection. Objective: This study aimed to identify and analyze key UX factors that support adoption and sustained use of PRO collection tools among patients with chronic diseases across multiple European countries. Methods: Patient focus groups were conducted in four chronic disease areas: cancer, inflammatory bowel disease (IBD), and diabetes (type I and II) across six European countries. Participants were recruited purposively through national patient advisory boards to ensure diversity in age, gender, and disease type. Sessions were moderated by trained qualitative researchers following a standardized guide, and discussions were transcribed verbatim and coded in researcher pairs to ensure intercoder reliability through iterative consensus. A modified thematic analysis, guided deductively by the UX Honeycomb model and inductively by emergent themes, was used to identify cross-disease UX determinants. Results: In total, 17 patients and patient representatives participated (76% female; 4 diabetes, 6 IBD and 7 cancer). We identified six core UX factors driving patient engagement for all disease groups: compatibility with other technologies, direct communication with the care team, personalization, ability to share data, the need for educational material and data protection were identified as key aspects of PRO technologies. However, the customizability of the app is crucial. Not all disease groups had the same needs, and participants specifically requested that the app provide information relevant to their own condition. Disease-specific needs, like T1D patients desiring glucose monitoring integration, were identified. IBD patients highlighted flare detection abilities and cancer patients especially sought side-effect comparisons. Conclusions: Our findings indicate that a unified yet customizable PRO platform can address shared UX needs across diseases, improving patient engagement and data quality. Incorporating features such as seamless data transfer, personalization, feedback, and strong privacy measures can foster trust and long-term adoption across European contexts. In addition to some disease-specific issues, most needs for the backbone of the app were shared among the disease areas. This shows that a shared app between diseases might be preferable and, in case of comorbidities, could ease self-management for patients. Last, to ensure full potential for every user and every disease, customization is crucial.
- 12 December 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (24) , 3272
Open AccessTracking Chronic Diseases via Mobile Health Applications: Which User Experience Aspects Are Key?
Background: A key barrier to realizing the full potential and long-term collection of patient-reported outcomes (PROs) is the limited understanding of user experience (UX) factors that influence sustained patient engagement with digital PRO tools. Most existing research focuses on disease-specific or country-specific solutions, leaving a gap in identifying shared UX determinants that could inform scalable, cross-disease European digital health frameworks. This fragmentation hinders interoperability and increases development costs by requiring separate tools for each context. This case study aims to address this gap by identifying key UX features that optimize PRO collection across diverse chronic conditions in Europe within the Health Outcomes Observatory project, enhancing continuous (primary use) and large-scale (secondary use) data collection. Objective: This study aimed to identify and analyze key UX factors that support adoption and sustained use of PRO collection tools among patients with chronic diseases across multiple European countries. Methods: Patient focus groups were conducted in four chronic disease areas: cancer, inflammatory bowel disease (IBD), and diabetes (type I and II) across six European countries. Participants were recruited purposively through national patient advisory boards to ensure diversity in age, gender, and disease type. Sessions were moderated by trained qualitative researchers following a standardized guide, and discussions were transcribed verbatim and coded in researcher pairs to ensure intercoder reliability through iterative consensus. A modified thematic analysis, guided deductively by the UX Honeycomb model and inductively by emergent themes, was used to identify cross-disease UX determinants. Results: In total, 17 patients and patient representatives participated (76% female; 4 diabetes, 6 IBD and 7 cancer). We identified six core UX factors driving patient engagement for all disease groups: compatibility with other technologies, direct communication with the care team, personalization, ability to share data, the need for educational material and data protection were identified as key aspects of PRO technologies. However, the customizability of the app is crucial. Not all disease groups had the same needs, and participants specifically requested that the app provide information relevant to their own condition. Disease-specific needs, like T1D patients desiring glucose monitoring integration, were identified. IBD patients highlighted flare detection abilities and cancer patients especially sought side-effect comparisons. Conclusions: Our findings indicate that a unified yet customizable PRO platform can address shared UX needs across diseases, improving patient engagement and data quality. Incorporating features such as seamless data transfer, personalization, feedback, and strong privacy measures can foster trust and long-term adoption across European contexts. In addition to some disease-specific issues, most needs for the backbone of the app were shared among the disease areas. This shows that a shared app between diseases might be preferable and, in case of comorbidities, could ease self-management for patients. Last, to ensure full potential for every user and every disease, customization is crucial.
- Open Access
- 2 October 2025
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 5, 1497055
Standardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set
Objectives: Patient-reported outcomes (PROs) are an essential component in the implementation of value-based health care. Up to now, no consensus exists on the appropriateness of PROs used across diseases, e.g., to allow for comparability or to assess disease impact. The aim of this study was to develop an international, multi-stakeholder consensus on a generic PRO set applicable for different stakeholders and diseases within of the Health Outcomes Observatory (H2O) project funded by the EU Innovative Medicines Initiative. Methods: To begin, a literature review was conducted to identify the most frequently utilized generic PROs followed by a three-round Delphi consensus procedure. The resulting outcome set was then cross-referenced with disease-specific outcome sets for lung and metastatic breast cancer, diabetes, and inflammatory bowel diseases to identify overlaps and gaps. Lastly, the identified generic outcome domains were mapped to the Max Neef's human needs model to explore the degree to which the generic domains address a general concept of wellbeing. Results: The literature search resulted in 2357 articles from which 190 PROMs and their measured domains were extracted. The Delphi consensus procedure reduced these to 10 core domains (mental, physical and social wellbeing, overall health status, fatigue, pain, sleep quality, sexuality, self-efficacy, treatment satisfaction). In comparison to the human needs model, needs such as identity and leisure were disregarded. Conclusions: The H2O generic outcome set presents a disease-generic, domain-centered PRO framework building the groundwork for health data spaces and supporting consistency in treatment outcomes across different sites, settings, and patient populations.
- 2 October 2025
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 5, 1497055
Open AccessStandardizing patient-reported outcomes across diseases: development of a novel generic patient-reported outcome set
Objectives: Patient-reported outcomes (PROs) are an essential component in the implementation of value-based health care. Up to now, no consensus exists on the appropriateness of PROs used across diseases, e.g., to allow for comparability or to assess disease impact. The aim of this study was to develop an international, multi-stakeholder consensus on a generic PRO set applicable for different stakeholders and diseases within of the Health Outcomes Observatory (H2O) project funded by the EU Innovative Medicines Initiative. Methods: To begin, a literature review was conducted to identify the most frequently utilized generic PROs followed by a three-round Delphi consensus procedure. The resulting outcome set was then cross-referenced with disease-specific outcome sets for lung and metastatic breast cancer, diabetes, and inflammatory bowel diseases to identify overlaps and gaps. Lastly, the identified generic outcome domains were mapped to the Max Neef's human needs model to explore the degree to which the generic domains address a general concept of wellbeing. Results: The literature search resulted in 2357 articles from which 190 PROMs and their measured domains were extracted. The Delphi consensus procedure reduced these to 10 core domains (mental, physical and social wellbeing, overall health status, fatigue, pain, sleep quality, sexuality, self-efficacy, treatment satisfaction). In comparison to the human needs model, needs such as identity and leisure were disregarded. Conclusions: The H2O generic outcome set presents a disease-generic, domain-centered PRO framework building the groundwork for health data spaces and supporting consistency in treatment outcomes across different sites, settings, and patient populations.
- 2 May 2025
- Published by Elsevier in The Lancet Rheumatology
- Vol. 7 (7) , e455-e457
Patient-reported outcomes: a new basis for prediction models?
- 2 May 2025
- Published by Elsevier in The Lancet Rheumatology
- Vol. 7 (7) , e455-e457
Patient-reported outcomes: a new basis for prediction models?
- Top Cited PapersOpen Access
- 5 February 2025
- Published by Springer Nature in Quality of Life Research
- Vol. 34 (5) , 1211-1220
The mere-measurement effect of patient-reported outcomes: a systematic review and meta-analysis
Purpose: The mere-measurement effect is the phenomenon in which subjects exposed to measurements have their perceptions and/or behaviors on the inquired topic affected simply through the act of responding. Patient-reported outcomes (PROs) are increasingly used to assess patient perspective and quality of life in clinical trials and different health care settings. This systematic literature review aims to assess what is currently known about the mere-measurement effect of PROs. Methods: A systematic literature review and meta-analysis was conducted. We included studies that provided evidence on perceptual or behavioral changes in patients as a result of exposure to questionnaire items assessing PROs. All adult participants were included regardless of demographics. Any study design was considered eligible for inclusion. The databases MEDLINE [PubMed], CINAHL [Ebsco], Web of Science and ScienceDirect were searched. Results: The search resulted in 636 articles which led to a final extraction of nine. Overall, seven of the nine articles reported a significant main effect, i.e. presence of the mere-measurement effect. For the meta-analysis, thirteen different interventions were included. There was a one-directional, positive and significant overall risk ratio of 1.17 [CI95% 1.04;1.30]. Conclusion: This systematic review found significant potential for the mere-measurement effect to shape respondents’ behaviors or perceptions for the better, opening the door to the possibility of engineering PROs to serve as a subtle intervention. Future considerations and directions for research are discussed.
- 5 February 2025
- Published by Springer Nature in Quality of Life Research
- Vol. 34 (5) , 1211-1220
Top Cited PapersOpen AccessThe mere-measurement effect of patient-reported outcomes: a systematic review and meta-analysis
Purpose: The mere-measurement effect is the phenomenon in which subjects exposed to measurements have their perceptions and/or behaviors on the inquired topic affected simply through the act of responding. Patient-reported outcomes (PROs) are increasingly used to assess patient perspective and quality of life in clinical trials and different health care settings. This systematic literature review aims to assess what is currently known about the mere-measurement effect of PROs. Methods: A systematic literature review and meta-analysis was conducted. We included studies that provided evidence on perceptual or behavioral changes in patients as a result of exposure to questionnaire items assessing PROs. All adult participants were included regardless of demographics. Any study design was considered eligible for inclusion. The databases MEDLINE [PubMed], CINAHL [Ebsco], Web of Science and ScienceDirect were searched. Results: The search resulted in 636 articles which led to a final extraction of nine. Overall, seven of the nine articles reported a significant main effect, i.e. presence of the mere-measurement effect. For the meta-analysis, thirteen different interventions were included. There was a one-directional, positive and significant overall risk ratio of 1.17 [CI95% 1.04;1.30]. Conclusion: This systematic review found significant potential for the mere-measurement effect to shape respondents’ behaviors or perceptions for the better, opening the door to the possibility of engineering PROs to serve as a subtle intervention. Future considerations and directions for research are discussed.
- Open Access
- 11 June 2024
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (6) , 759
Temporal Recall Strategies in Rheumatoid Arthritis Patients’ Emotionally Intense Life Events
Background: Rheumatoid arthritis (RA) patients often encounter psychological challenges due to chronic pain, fatigue, side effects of medications, and disability. This study examines the relationship between autobiographical narratives and recollection patterns in RA patients. We investigated how different recall strategies for positive life events affect the emotional processing of negative episodes. We hypothesized that vividly recalling positive life events provides psychological resources that support a more intense emotional elaboration of stressful memories, allowing individuals to delve deeper into negative life experiences. Additionally, we explored the impact of these perspectives on self-reported well-being and physical health, proposing that re-living positive events improves overall well-being. Methods: We collected and analyzed high-point and low-point life-story episodes from 60 RA patients (85% female; age mean 61 ± 11 years; range 37–79) using episodic narrative interviews and the Narrative Categorical Content Analysis algorithm (NarrCat). Participants were categorized into 2 clusters based on their temporal perspective during high-point episodes: 25 used a Retrospective viewpoint, while 35 employed a Re-experiencing strategy. Depression and anxiety were assessed with the Hospital Anxiety and Depression Scale (HADS), and functioning was measured using the Health Assessment Questionnaire (HAQ). Results: The Re-experiencing group, which was more likely to articulate their high-point episode in vivid and real-time narrative, used more psychological perspectives (U(58) = 223, p < 0.01) and showed heightened emotional frequency (U(58) = 280, p < 0.05; positive: U(58) = 328, p < 0.05; negative: U(58) = 278, p < 0.05) in low-point episodes. No significant difference emerged between the two groups regarding psychological state (anxiety, depressive symptoms) and physical impairment. Conclusions: Vividly recalling positive events may facilitate a deeper exploration of negative memories. The Re-experiencing group showed increased positive emotions during low points, suggesting better emotion regulation. However, no significant association was found between recalling strategies, psychological state, and physical impairment. This indicates that further research is needed to determine whether re-experiencing positive life events is adaptive or maladaptive.
- 11 June 2024
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (6) , 759
Open AccessTemporal Recall Strategies in Rheumatoid Arthritis Patients’ Emotionally Intense Life Events
Background: Rheumatoid arthritis (RA) patients often encounter psychological challenges due to chronic pain, fatigue, side effects of medications, and disability. This study examines the relationship between autobiographical narratives and recollection patterns in RA patients. We investigated how different recall strategies for positive life events affect the emotional processing of negative episodes. We hypothesized that vividly recalling positive life events provides psychological resources that support a more intense emotional elaboration of stressful memories, allowing individuals to delve deeper into negative life experiences. Additionally, we explored the impact of these perspectives on self-reported well-being and physical health, proposing that re-living positive events improves overall well-being. Methods: We collected and analyzed high-point and low-point life-story episodes from 60 RA patients (85% female; age mean 61 ± 11 years; range 37–79) using episodic narrative interviews and the Narrative Categorical Content Analysis algorithm (NarrCat). Participants were categorized into 2 clusters based on their temporal perspective during high-point episodes: 25 used a Retrospective viewpoint, while 35 employed a Re-experiencing strategy. Depression and anxiety were assessed with the Hospital Anxiety and Depression Scale (HADS), and functioning was measured using the Health Assessment Questionnaire (HAQ). Results: The Re-experiencing group, which was more likely to articulate their high-point episode in vivid and real-time narrative, used more psychological perspectives (U(58) = 223, p < 0.01) and showed heightened emotional frequency (U(58) = 280, p < 0.05; positive: U(58) = 328, p < 0.05; negative: U(58) = 278, p < 0.05) in low-point episodes. No significant difference emerged between the two groups regarding psychological state (anxiety, depressive symptoms) and physical impairment. Conclusions: Vividly recalling positive events may facilitate a deeper exploration of negative memories. The Re-experiencing group showed increased positive emotions during low points, suggesting better emotion regulation. However, no significant association was found between recalling strategies, psychological state, and physical impairment. This indicates that further research is needed to determine whether re-experiencing positive life events is adaptive or maladaptive.
- Open Access
- 1 January 2024
- Published by BMJ in BMJ Mental Health
- Vol. 27 (1) , e301061
Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals
Background Diabetes increases the risk of psychosocial health problems. Person-centred psychosocial care is therefore advocated. However, several barriers to implementation exist, including uncertainty about how to approach psychosocial problems in consultations. Objective We aimed to explore which psychosocial outcomes patients and healthcare professionals consider important and whether certain characteristics are associated with this. We propose strategies for facilitating psychosocial diabetes care on this basis. Methods The results of an international Delphi study aimed at achieving multi-stakeholder consensus on a diabetes outcome set were analysed. We compared the importance ratings of the two stakeholder groups for each psychosocial outcome. A multivariable linear regression analysis tested whether certain characteristics would predict the importance attributed to outcomes that were not generally considered important. Findings Patients and healthcare professionals agreed on the importance of regularly assessing psychological well-being, diabetes distress and diabetes-specific quality of life, while they regarded it as less important to monitor depression, anxiety, eating problems, social support and sexual health. Being a woman, younger and living with type 1 diabetes were associated with considering it important to assess eating problems. Conclusions We propose two psychosocial care pathways that reflect the outcome preferences of patients and healthcare providers. They follow a stepped approach, starting with the assessment of psychological well-being and quality of life and proceeding from there. Clinical implications Adopting this approach can facilitate the implementation of person-centred psychosocial diabetes care by reducing the burden and making psychosocial issues more accessible. This approach should be tested for feasibility, safety and effectiveness.
- 1 January 2024
- Published by BMJ in BMJ Mental Health
- Vol. 27 (1) , e301061
Open AccessPutting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals
Background Diabetes increases the risk of psychosocial health problems. Person-centred psychosocial care is therefore advocated. However, several barriers to implementation exist, including uncertainty about how to approach psychosocial problems in consultations. Objective We aimed to explore which psychosocial outcomes patients and healthcare professionals consider important and whether certain characteristics are associated with this. We propose strategies for facilitating psychosocial diabetes care on this basis. Methods The results of an international Delphi study aimed at achieving multi-stakeholder consensus on a diabetes outcome set were analysed. We compared the importance ratings of the two stakeholder groups for each psychosocial outcome. A multivariable linear regression analysis tested whether certain characteristics would predict the importance attributed to outcomes that were not generally considered important. Findings Patients and healthcare professionals agreed on the importance of regularly assessing psychological well-being, diabetes distress and diabetes-specific quality of life, while they regarded it as less important to monitor depression, anxiety, eating problems, social support and sexual health. Being a woman, younger and living with type 1 diabetes were associated with considering it important to assess eating problems. Conclusions We propose two psychosocial care pathways that reflect the outcome preferences of patients and healthcare providers. They follow a stepped approach, starting with the assessment of psychological well-being and quality of life and proceeding from there. Clinical implications Adopting this approach can facilitate the implementation of person-centred psychosocial diabetes care by reducing the burden and making psychosocial issues more accessible. This approach should be tested for feasibility, safety and effectiveness.